Dark Forest Capital Management’s Charles River Laboratories CRL Stock Holding History

Dark Forest Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,405	Closed	-$652K	–	696
2024 Q1	$652K	Buy	+2,405	New	+$574K	0.11%	193
2023 Q4	–	Sell	-3,565	Closed	-$699K	–	601
2023 Q3	$699K	Buy	3,565 +861	+32%	+$177K	0.05%	569
2023 Q2	$569K	Buy	+2,704	New	+$538K	0.05%	585
2023 Q1	–	Sell	-12	Closed	-$2.62K	–	1217
2022 Q4	$2.62K	Buy	+12	New	+$2.62K	﹤0.01%	928
2022 Q3	–	Sell	-3	Closed	-$1K	–	1187
2022 Q2	$1K	Buy	+3	New	+$733	﹤0.01%	774
2022 Q1	–	Sell	-63	Closed	-$24K	–	1361
2021 Q4	$24K	Buy	63 +6	+11%	+$2.33K	0.01%	623
2021 Q3	$24K	Buy	+57	New	+$23.7K	0.01%	758

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Dark Forest Capital Management's CRL Position: Q2 2024 in Review

Dark Forest Capital Management sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 2,405 shares — an estimated $652K sold.

Dark Forest Capital Management first reported a position in CRL in Q3 2021 and held it in 7 quarters. The position peaked at $699K in Q3 2023. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

Dark Forest Capital Management reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
Dark Forest Capital Management sold 2,405 Charles River Laboratories shares in Q2 2024, an estimated $652K.
Dark Forest Capital Management first reported a position in Charles River Laboratories in Q3 2021 and held it in 7 quarters.
Dark Forest Capital Management's Charles River Laboratories position peaked at $699K in Q3 2023.
665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Dark Forest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.